Innate Pharma (IPHA) Exchange Rate Effect (2018 - 2024)
Innate Pharma's (IPHA) quarterly Exchange Rate Effect came in at -$539640.7 in Q4 2024, down 94.98% on a QoQ basis from -$276760.1 in Q2 2024.
Innate Pharma (IPHA) Exchange Rate Effect (2018 - 2024) Analysis & Trends
Innate Pharma (IPHA) has 6 years of Exchange Rate Effect data on file, last reported at -$539640.7 in Q4 2024.
- Quarterly Exchange Rate Effect changed N/A year-over-year to -$539640.7 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$2.0 million (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, up 335.55% from the prior year.
- Exchange Rate Effect slipped to -$539640.7 in Q4 2024, from -$276760.1 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of -$14319.0 in Q2 2020 to a low of -$714928.0 in Q2 2022.
- A 4-year average of -$392744.6 and a median of -$436665.9 in 2022 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect sank 1397.04% — and 2022, when it increased 20.97%.
- Tracing IPHA's Exchange Rate Effect over 4 years: stood at -$14319.0 in 2020, then plunged by 3758.78% to -$552538.0 in 2021, then increased by 20.97% to -$436665.9 in 2022, then dropped by 23.58% to -$539640.7 in 2024.
- The last three Exchange Rate Effect figures came in at -$539640.7 (Q4 2024), -$276760.1 (Q2 2024), and -$436665.9 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.56 Bn | 78.56 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.72 Bn | 60.53 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.75 Bn | 53.61 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.59 Bn | 10.19 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.63 Bn | 26.47 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.24 Bn | 26.40 Bn | - | - |
| 10 | Innate Pharma | 205.16 Mn | 205.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -539,640.68 |
| Dec 31, 2024 | -539,640.68 |
| Jun 30, 2024 | -276,760.11 |
| Jun 30, 2024 | -276,760.11 |
| Dec 31, 2022 | -436,665.87 |
| Dec 31, 2022 | -436,665.87 |
| Jun 30, 2022 | -714,927.98 |
| Jun 30, 2022 | -714,927.98 |
| Dec 31, 2021 | -552,537.97 |
| Dec 31, 2021 | -552,537.97 |
| Jun 30, 2021 | -214,360.32 |
| Jun 30, 2021 | -214,360.32 |
| Jun 30, 2020 | -14,318.98 |
| Jun 30, 2020 | -14,318.98 |
| Dec 31, 2019 | 224.57 Mn |
| Dec 31, 2019 | 224.57 Mn |
| Jun 30, 2019 | -3,370.92 |
| Jun 30, 2019 | -3,370.92 |
| Dec 31, 2018 | 173.85 Mn |
| Dec 31, 2018 | 173.85 Mn |